SMTL ID : 7qkc.1 (3 other biounits)

Crystal structure of human Cathepsin L after incubation with Sulfo-Calpeptin

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.1: 6 residues within 4Å: Chain A: Q.19, G.20, Q.21, C.22, L.144, W.189 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.21 Water bridges: A:W.189 PEG.2: 6 residues within 4Å: Chain A: S.88, Y.89, P.90, K.99, N.101, Y.104 No protein-ligand interaction detected (PLIP)

1 x RN2: Calpeptin(Non-covalent)

RN2.3: 21 residues within 4Å: Chain A: Q.19, C.22, G.23, S.24, C.25, W.26, G.61, N.62, E.63, C.65, N.66, G.67, G.68, L.69, M.70, Y.72, A.135, M.161, D.162, H.163, G.164 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:E.63, A:L.69 Hydrogen bonds: A:Q.19, A:C.25, A:G.68, A:G.68, A:D.162 Water bridges: A:Q.19, A:H.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Reinke, P.Y.A. et al., Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Commun Biol (2023)

Release Date

2022-12-28

Peptides

Cathepsin L: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cathepsin L

Related Entries With Identical Sequence